Low urgency

Andrew Jonathan Morgan: Final Debarment Order

Detected July 30, 2026 · in Pharmaceutical Manufacturing (FDA/DEA)

FDA debars Andrew Jonathan Morgan for 5 years from importing or offering for import any drug.

Aforeworn detected this change in the Pharmaceutical Manufacturing (FDA/DEA) space on July 30, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Low urgency. Andrew Jonathan Morgan (individual), and any business that relies on him for drug import activities. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Immediately upon issuance of the order (June 17, 2026).. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmaceutical Manufacturing (FDA/DEA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.

What changed

Andrew Jonathan Morgan is now debarred for 5 years from importing or offering for import any drug under the FD&C Act.

Who it affects

Andrew Jonathan Morgan (individual), and any business that relies on him for drug import activities.

What you must do

Businesses should verify that Andrew Jonathan Morgan is not involved in any drug import activities and remove him from such roles immediately.

Deadline

Immediately upon issuance of the order (June 17, 2026).

Source: https://www.federalregister.gov/documents/2026/06/17/2026-12167/andrew-jonathan-morgan-final-debarment-order

Never miss a change like this again

Aforeworn watches Pharmaceutical Manufacturing (FDA/DEA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.

Start your free trial

Related changes in Pharmaceutical Manufacturing (FDA/DEA)